C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

C4 Therapeutics, a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced that the Company will present at the 40th Annual J.P. Morgan Healthcare Conference.

Read More on C4 Therapeutics

Related posts